[Treatment of brucellosis with the tetracycline-oleandomycin combination].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002006:Brucellosis / Q000628:therapy*; D003879:Dermatologic Agents; D006801:Humans; D009827:Oleandomycin; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D011500:Protein Synthesis Inhibitors; D013752:Tetracycline; D009827:Oleandomycin
ANTIBIOTICS/therapeutic use; BRUCELLOSIS/therapy; TETRACYCLINE/therapeutic use
Tratamiento de la brucelosis con la asociación tetraciclina oleandomicina.